Literature DB >> 8845863

The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking.

D E Comings1, L Ferry, S Bradshaw-Robinson, R Burchette, C Chiu, D Muhleman.   

Abstract

Of a group of 312 non-Hispanic Caucasians who smoked at least one pack per day, had unsuccessfully attempted to stop smoking, and were free of alcohol or other drug dependence, 48.7% carried the A1 allele of the DRD2 gene. This was significantly greater than the 25.9% prevalence in the 714 known non-Hispanic Caucasian controls without alcohol or drug abuse, p < 10(-8), and significantly greater than in a smaller set of our study controls. There was a significant, inverse relationship between the prevalence of the D2A1 allele and the age of onset of smoking, p = 0.02, and the maximum duration of time the smokers had been able to quit smoking on their own, p = 0.02. These results suggest the DRD2 gene is one of a multifactorial set of risk factors associated with smoking.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8845863     DOI: 10.1097/00008571-199602000-00006

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  59 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

Review 3.  Genetics and smoking behavior.

Authors:  Robert A Schnoll; Terrance A Johnson; Caryn Lerman
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 4.  Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.

Authors:  Marcus R Munafò; Nicholas J Timpson; Sean P David; Shah Ebrahim; Debbie A Lawlor
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

Review 5.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

6.  The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls.

Authors:  Jessica Clague; Paul Cinciripini; Janice Blalock; Xifeng Wu; Karen S Hudmon
Journal:  Behav Genet       Date:  2009-10-15       Impact factor: 2.805

Review 7.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 8.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.

Authors:  San-Yuan Huang; Wei-Wen Lin; Fang-Jung Wan; Ai-Ju Chang; Huei-Chen Ko; Tso-Jen Wang; Pei-Lin Wu; Ru-Band Lu
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

10.  The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.

Authors:  Mindi A Styn; Tomoko Nukui; Marjorie Romkes; Kenneth Perkins; Stephanie R Land; Joel L Weissfeld
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.